October 1, 2026
Astrocyte Pharmaceuticals
Astrocyte Pharmaceuticals, a Groton, Conn.-based cerebroprotective therapy biotech, raised $9.5 million in Series B funding.
- Round
- Series B
- Amount raised
- $9.5M
- Lead investor
- DeepWork Capital
- Industry
- Cerebroprotective therapy biotech
- Headquarters
- Groton
- Employees
- 2-10 employees
- Website
- astrocytepharma.com
- View profile →
Other investors
- MintPharma Capital
- Waterstar Capital
- Dynagrow Capital
- Angel Star Ventures
Source: Axios Pro Rata